BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8555242)

  • 1. The molecular structure of apolipoprotein A-II modulates the capacity of HDL to promote cell cholesterol efflux.
    Bernini F; Calabresi L; Bonfadini G; Franceschini G
    Biochim Biophys Acta; 1996 Jan; 1299(1):103-9. PubMed ID: 8555242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios.
    von Hodenberg E; Heinen S; Howell KE; Luley C; Kübler W; Bond HM
    Biochim Biophys Acta; 1991 Nov; 1086(2):173-84. PubMed ID: 1932099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.
    Li Q; Tsujita M; Yokoyama S
    Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L; Canavesi M; Bernini F; Franceschini G
    Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
    Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
    Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation.
    Nakamura R; Ohta T; Ikeda Y; Matsuda I
    Arterioscler Thromb; 1993 Sep; 13(9):1307-16. PubMed ID: 8364015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
    Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
    J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-II inhibits the formation of pre-beta high density lipoproteins.
    Calabresi L; Lucchini A; Vecchio G; Sirtori CR; Franceschini G
    Biochim Biophys Acta; 1996 Nov; 1304(1):32-42. PubMed ID: 8944748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.
    Gauthamadasa K; Vaitinadin NS; Dressman JL; Macha S; Homan R; Greis KD; Silva RA
    J Biol Chem; 2012 Mar; 287(10):7615-25. PubMed ID: 22235130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
    Sviridov D; Pyle L; Fidge N
    Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
    Komaba A; Li Q; Hara H; Yokoyama S
    J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice.
    Hayek T; Oiknine J; Brook JG; Aviram M
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1072-8. PubMed ID: 7802634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.